175 related articles for article (PubMed ID: 20332278)
1. Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
Bolton KL; Garcia-Closas M; Pfeiffer RM; Duggan MA; Howat WJ; Hewitt SM; Yang XR; Cornelison R; Anzick SL; Meltzer P; Davis S; Lenz P; Figueroa JD; Pharoah PD; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):992-9. PubMed ID: 20332278
[TBL] [Abstract][Full Text] [Related]
2. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
[TBL] [Abstract][Full Text] [Related]
3. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW
Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
[TBL] [Abstract][Full Text] [Related]
5. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
[TBL] [Abstract][Full Text] [Related]
6. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C
World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362
[TBL] [Abstract][Full Text] [Related]
7. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Turbin DA; Leung S; Cheang MC; Kennecke HA; Montgomery KD; McKinney S; Treaba DO; Boyd N; Goldstein LC; Badve S; Gown AM; van de Rijn M; Nielsen TO; Gilks CB; Huntsman DG
Breast Cancer Res Treat; 2008 Aug; 110(3):417-26. PubMed ID: 17912629
[TBL] [Abstract][Full Text] [Related]
8. Reliability of a computational platform as a surrogate for manually interpreted immunohistochemical markers in breast tumor tissue microarrays.
Roberts MR; Baker GM; Heng YJ; Pyle ME; Astone K; Rosner BA; Collins LC; Eliassen AH; Tamimi RM
Cancer Epidemiol; 2021 Oct; 74():101999. PubMed ID: 34352659
[TBL] [Abstract][Full Text] [Related]
9. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract][Full Text] [Related]
10. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
[TBL] [Abstract][Full Text] [Related]
11. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B
Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664
[TBL] [Abstract][Full Text] [Related]
12. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
Howat WJ; Blows FM; Provenzano E; Brook MN; Morris L; Gazinska P; Johnson N; McDuffus LA; Miller J; Sawyer EJ; Pinder S; van Deurzen CH; Jones L; Sironen R; Visscher D; Caldas C; Daley F; Coulson P; Broeks A; Sanders J; Wesseling J; Nevanlinna H; Fagerholm R; Blomqvist C; Heikkilä P; Ali HR; Dawson SJ; Figueroa J; Lissowska J; Brinton L; Mannermaa A; Kataja V; Kosma VM; Cox A; Brock IW; Cross SS; Reed MW; Couch FJ; Olson JE; Devillee P; Mesker WE; Seyaneve CM; Hollestelle A; Benitez J; Perez JI; Menéndez P; Bolla MK; Easton DF; Schmidt MK; Pharoah PD; Sherman ME; García-Closas M
J Pathol Clin Res; 2015 Jan; 1(1):18-32. PubMed ID: 27499890
[TBL] [Abstract][Full Text] [Related]
13. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
[TBL] [Abstract][Full Text] [Related]
14. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.
Akbar S; Jordan LB; Purdie CA; Thompson AM; McKenna SJ
Br J Cancer; 2015 Sep; 113(7):1075-80. PubMed ID: 26348443
[TBL] [Abstract][Full Text] [Related]
15. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.
Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ
BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031
[TBL] [Abstract][Full Text] [Related]
16. Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.
Turashvili G; Leung S; Turbin D; Montgomery K; Gilks B; West R; Carrier M; Huntsman D; Aparicio S
BMC Cancer; 2009 May; 9():165. PubMed ID: 19476653
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.
Rizzardi AE; Zhang X; Vogel RI; Kolb S; Geybels MS; Leung YK; Henriksen JC; Ho SM; Kwak J; Stanford JL; Schmechel SC
Diagn Pathol; 2016 Jul; 11(1):63. PubMed ID: 27401406
[TBL] [Abstract][Full Text] [Related]
18. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.
Ali HR; Irwin M; Morris L; Dawson SJ; Blows FM; Provenzano E; Mahler-Araujo B; Pharoah PD; Walton NA; Brenton JD; Caldas C
Br J Cancer; 2013 Feb; 108(3):602-12. PubMed ID: 23329232
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
Abubakar M; Orr N; Daley F; Coulson P; Ali HR; Blows F; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Devilee P; Tollenaar RA; Seynaeve C; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Wesseling J; van Leeuwen FE; Van 't Veer L; Easton D; Swerdlow AJ; Dowsett M; Pharoah PD; Schmidt MK; Garcia-Closas M
Breast Cancer Res; 2016 Oct; 18(1):104. PubMed ID: 27756439
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay: A 10-Year Experience and Impact of Test Standardization on Concordance Rate.
Sarode VR; Xiang QD; Christie A; Collins R; Rao R; Leitch AM; Euhus D; Haley B
Arch Pathol Lab Med; 2015 Jul; 139(7):922-8. PubMed ID: 26125432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
